Mead Johnson Nutrition (NYSE: MJN) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), Mead Johnson Nutrition beat slightly on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share grew. GAAP earnings per share contracted.

Gross margins increased, operating margins dropped, net margins dropped.

Revenue details
 Mead Johnson Nutrition notched revenue of $1.06 billion. The 10 analysts polled by S&P Capital IQ looked for revenue of $1.04 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.84. The 13 earnings estimates compiled by S&P Capital IQ anticipated $0.83 per share. Non-GAAP EPS of $0.84 for Q2 were 1.2% higher than the prior-year quarter's $0.83 per share. GAAP EPS of $0.80 for Q2 were 1.2% lower than the prior-year quarter's $0.81 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 63.6%, 40 basis points better than the prior-year quarter. Operating margin was 21.9%, 300 basis points worse than the prior-year quarter. Net margin was 15.4%, 100 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $1.00 billion. On the bottom line, the average EPS estimate is $0.78.

Next year's average estimate for revenue is $4.13 billion. The average EPS estimate is $3.23.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 84 members out of 103 rating the stock outperform, and 19 members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give Mead Johnson Nutrition a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is hold, with an average price target of $82.96.

The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.